These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35499305)

  • 21. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the pH-Dependent Solubility of Various Grades of Calcium Phosphate-based Pharmaceutical Excipients.
    Wagner M; Hess T; Zakowiecki D
    J Pharm Sci; 2022 Jun; 111(6):1749-1760. PubMed ID: 34890630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
    Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
    Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.
    Yang E; Yoo H; Jang IJ; Yu KS; Lee S
    Drug Des Devel Ther; 2021; 15():651-658. PubMed ID: 33628012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the method of preparation on the compression, mechanical, and release properties of khaya gum matrices.
    Odeku OA; Fell JT
    Pharm Dev Technol; 2006; 11(4):435-41. PubMed ID: 17101514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Water Sorption in Tablet Crushing Strength, Disintegration, and Dissolution.
    Sacchetti M; Teerakapibal R; Kim K; Elder EJ
    AAPS PharmSciTech; 2017 Aug; 18(6):2214-2226. PubMed ID: 28070847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of empagliflozin immediate release tablets (10 mg) using central composite rotatable design with response surface methodology.
    M Hanif A; Bushra R; Iffat W; Ghayas S; Perveen S; Riaz H; Alam S; Ali SI; Ismail NE; Un-Nisa Z
    Pak J Pharm Sci; 2021 Jul; 34(4(Supplementary)):1519-1525. PubMed ID: 34799327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
    AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low- and high-humidity ageing on the hardness, disintegration time and dissolution rate of dibasic calcium phosphate-based tablets.
    Chowhan ZT
    J Pharm Pharmacol; 1980 Jan; 32(1):10-4. PubMed ID: 6102119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To Maintain Formulation Composition Similarity of Coated Tablets of Different Strengths: Should Coating be Based on Core Tablet Weight or Surface Area?
    Reddy JP; Vyas G; Patel R; Rana S; Mansuri N; Dimuthu J; Shah T; Desai D
    Pharm Res; 2020 Sep; 37(10):201. PubMed ID: 32968862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of dissolution and disintegration results for an immediate-release tablet.
    Nickerson B; Kong A; Gerst P; Kao S
    J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Optimization of Self-emulsifying Drug Delivery Systems (SEDDS) for Enhanced Dissolution and Permeability of Rosuvastatin.
    Karasulu HY; Gündoğdu E; Turgay T; Türk UÖ; Apaydın S; Şimşir IY; Yilmaz C; Karasulu E
    Curr Drug Deliv; 2016; 13(3):362-70. PubMed ID: 27230902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Practical Framework Toward Prediction of Breaking Force and Disintegration of Tablet Formulations Using Machine Learning Tools.
    Akseli I; Xie J; Schultz L; Ladyzhynsky N; Bramante T; He X; Deanne R; Horspool KR; Schwabe R
    J Pharm Sci; 2017 Jan; 106(1):234-247. PubMed ID: 28340955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding.
    Rush SD; Vernak C; Zhao F
    Int J Pharm Compd; 2017; 21(1):83-87. PubMed ID: 28346201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
    Surampalli G; Nanjwade BK; Patil PA; Chilla R
    Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of starch-clay composites as a pharmaceutical excipient in tramadol tablet formulations.
    Alabi CO; Singh I; Odeku OA
    Polim Med; 2020; 50(1):33-40. PubMed ID: 33125195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.